ArriVent BioPharma (AVBP) Institutional Ownership $26.63 +0.60 (+2.31%) (As of 01:00 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ArriVent BioPharma (NASDAQ:AVBP)CurrentInstitutional OwnershipPercentage9.48%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$131.99MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.78M Get AVBP Insider Trade Alerts Want to know when executives and insiders are buying or selling ArriVent BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AVBP Institutional Buying and Selling by Quarter Ad DTI[PDF] The Opportunity in GoldCommodities expert, Geof Smith, insists that the supercycle on gold is just getting warmed up. In fact, even though gold looks like this since he initially called a major bull run 11 months ago… He’s still predicting it will be the TOP trade of 2025. His free eBook explains why You see, the last time gold launched into a supercycle like this it surged 536% The time before that was over 1,000%... That’s why Geof released this urgent guide to help you. Most people think they’ve missed out, but he thinks we’re at the very beginning of what could be the largest gold rally of our lifetimes. But, believe it or not, Geof doesn’t think you should just buy and hold precious metals. He’ll share more about his approach inside the eBook and it might surprise you.Tap here to read it ArriVent BioPharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC41,522$976K0.0%+1,124.8%0.123% 11/16/2024 Geode Capital Management LLC597,165$14.04M0.0%+154.2%1.778% 11/15/2024 Barclays PLC41,522$976K0.0%+1,124.8%0.124% 11/15/2024 Jane Street Group LLC10,626$250K0.0%-30.7%0.032% 11/15/2024 State Street Corp476,809$11.21M0.0%+210.4%1.419% 11/14/2024 Suvretta Capital Management LLC1,845,162$43.36M1.4%+7.7%5.493% Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 MetLife Investment Management LLC16,350$384K0.0%+168.9%0.049% 11/13/2024 BNP Paribas Financial Markets21,965$516K0.0%+32.6%0.065% 11/13/2024 FMR LLC2,119,695$49.81M0.0%+8.7%6.310% 11/13/2024 The Manufacturers Life Insurance Company10,234$240K0.0%N/A0.030% 11/12/2024 Charles Schwab Investment Management Inc.202,368$4.76M0.0%+153.8%0.602% 10/30/2024 AlphaCentric Advisors LLC15,000$352K0.3%-82.6%0.045% 10/24/2024 Novo Holdings A S1,505,315$35.38M1.8%+0.4%4.494% 10/3/2024 SG Americas Securities LLC11,927$280K0.0%N/A0.036% 8/20/2024 Novo Holdings A S1,500,000$27.83M1.4%+39.3%4.478% 8/1/2024 Rhumbline Advisers12,707$236K0.0%+30.1%0.038% 7/26/2024 Bank of New York Mellon Corp29,847$554K0.0%+31.4%0.089% 7/26/2024 AlphaCentric Advisors LLC86,000$1.60M1.2%+3.6%0.257% 5/24/2024 Farallon Capital Management LLC151,768$2.71M0.0%N/A0.453% 5/16/2024 Blackstone Inc.25,000$446K0.0%N/A0.075% 5/15/2024 Hhlr Advisors LTD.3,929,117$70.17M1.5%N/A11.732% 5/15/2024 Altitude Crest Partners Inc.555,555$9.92M4.2%N/A1.659% 5/14/2024 American International Group Inc.4,845$87K0.0%N/A0.014% 5/10/2024 Vanguard Group Inc.648,735$11.59M0.0%N/A1.937% 5/1/2024 BNP Paribas Financial Markets4,659$83K0.0%N/A0.014% (Data available from 1/1/2016 forward) AVBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AVBP shares? During the previous two years, 21 institutional investors and hedge funds held shares of ArriVent BioPharma. The most heavily invested institutionals were Hhlr Advisors LTD. ($70.17M), FMR LLC ($49.81M), Suvretta Capital Management LLC ($43.36M), Novo Holdings A S ($35.38M), Geode Capital Management LLC ($14.04M), Vanguard Group Inc. ($11.59M), and State Street Corp ($11.21M).Learn more on AVBP's institutional investors. What percentage of ArriVent BioPharma stock is owned by institutional investors? 9.48% of ArriVent BioPharma stock is owned by institutional investors. Learn more on AVBP's institutional investor holdings. Which institutional investors have been buying ArriVent BioPharma stock? Of the 20 institutional investors that purchased ArriVent BioPharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Hhlr Advisors LTD. ($3.93M), Vanguard Group Inc. ($648.74K), Altitude Crest Partners Inc. ($555.56K), Novo Holdings A S ($428.18K), Geode Capital Management LLC ($362.22K), State Street Corp ($323.19K), and FMR LLC ($169.51K). How much institutional buying is happening at ArriVent BioPharma? Institutional investors have bought a total of 6,985,048 shares in the last 24 months. This purchase volume represents approximately $131.99M in transactions. Which ArriVent BioPharma major shareholders have been selling company stock? The following institutional investors have sold ArriVent BioPharma stock in the last 24 months: AlphaCentric Advisors LLC ($71K), and Jane Street Group LLC ($4.71K). How much institutional selling is happening at ArriVent BioPharma? Institutional investors have sold a total of 75,707 shares in the last 24 months. This volume of shares sold represents approximately $1.78M in transactions. Related Companies Verona Pharma Institutional Ownership Rhythm Pharmaceuticals Institutional Ownership MoonLake Immunotherapeutics Institutional Ownership Janux Therapeutics Institutional Ownership Edgewise Therapeutics Institutional Ownership Xenon Pharmaceuticals Institutional Ownership Merus Institutional Ownership ACADIA Pharmaceuticals Institutional Ownership Twist Bioscience Institutional Ownership MorphoSys Institutional Ownership This page (NASDAQ:AVBP) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVBP Stock Alerts